Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.
Pharmacogenomics
; 18(4): 359-367, 2017 Mar.
Article
en En
| MEDLINE
| ID: mdl-28244812
ABSTRACT
AIM:
To investigate provider utilization of pharmacist support in the delivery of pharmacogenetic testing in a primary care setting.METHODS:
Two primary care clinics within Duke University Health System participated in the study between December 2012 and July 2013. One clinic was provided with an in-house pharmacist and the second clinic had an on-call pharmacist.RESULTS:
Providers in the in-house pharmacist arm consulted with the pharmacist for 13 of 15 cases, or about one of every four patients tested compared with one of every 7.5 patients in the on-call pharmacist arm. A total of 63 tests were ordered, 48 by providers in the pharmacist-in-house arm.CONCLUSION:
These findings suggest that the availability of an in-house pharmacist increases the likelihood of pharmacogenetic test utilization.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Farmacéuticos
/
Atención Primaria de Salud
/
Rol Profesional
/
Atención a la Salud
/
Médicos de Atención Primaria
/
Pruebas de Farmacogenómica
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Aspecto:
Determinantes_sociais_saude
Límite:
Female
/
Humans
/
Male
Idioma:
En
Revista:
Pharmacogenomics
Asunto de la revista:
FARMACOLOGIA
/
GENETICA MEDICA
Año:
2017
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
ENGLAND
/
ESCOCIA
/
GB
/
GREAT BRITAIN
/
INGLATERRA
/
REINO UNIDO
/
SCOTLAND
/
UK
/
UNITED KINGDOM